Glaukos (NYSE:GKOS) Given “Buy” Rating at BTIG Research

Glaukos (NYSE:GKOS) Given “Buy” Rating at BTIG Research

BTIG Research restated their buy rating on shares of Glaukos (NYSE:GKOS – Free Report) in a research note released on Friday, Marketbeat Ratings reports. The firm currently has a $116.00 price objective on the medical instruments supplier’s stock. Several other research analysts also recently commented on the stock. Citigroup increased their price objective on shares of Glaukos from $113.00 to $125.00 and gave the company a “buy” rating in a rep…

Glaukos (NYSE:GKOS) Earns “Buy” Rating from BTIG Research

Glaukos (NYSE:GKOS – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at BTIG Research in a note issued to investors on Friday,Benzinga reports. They currently have a $116.00 target price on the medical instruments supplier’s stock. BTIG Research’s price objective suggests a potential upside of 2.84% from the stock’s previous […]